PBA
Paradigm Biocapital Advisors Portfolio holdings
AUM
$2.34B
This Quarter Return
-11.44%
1 Year Return
+13.3%
3 Year Return
+245.82%
5 Year Return
–
10 Year Return
–
AUM
$2.17B
AUM Growth
+$2.17B
(-24%)
Cap. Flow
-$235M
Cap. Flow
% of AUM
-10.8%
Top 10 Holdings %
Top 10 Hldgs %
76.41%
Holding
33
New
5
Increased
11
Reduced
10
Closed
6
Top Buys
| 1 |
Merus
MRUS
|
$70.7M |
| 2 |
Cytokinetics
CYTK
|
$34.5M |
| 3 |
Insmed
INSM
|
$34.4M |
| 4 |
MTSR
Metsera, Inc. Common Stock
MTSR
|
$32.4M |
| 5 |
Cogent Biosciences
COGT
|
$24.2M |
Top Sells
| 1 |
argenx
ARGX
|
$250M |
| 2 |
Vera Therapeutics
VERA
|
$60.8M |
| 3 |
MoonLake Immunotherapeutics
MLTX
|
$44.7M |
| 4 |
Pliant Therapeutics
PLRX
|
$42.1M |
| 5 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
$22.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ocular Therapeutix
OCUL
$2.12B
| $9.63M | 0.44% | +1,314,018 | New | +$9.63M |
|
27
Immatics
IMTX
$619M
| $8.6M | 0.39% | 1,907,108 -3,507,301 | -65% | -$15.8M |
|
28
Agios Pharmaceuticals
AGIO
$2.19B
| – | – | -276,439 | Closed | -$9.08M |
|
|
29
Pliant Therapeutics
PLRX
$101M
| – | – | -3,197,050 | Closed | -$42.1M |
|
30
Scholar Rock
SRRK
$3.14B
| – | – | -400,000 | Closed | -$17.3M |
|
|
31
Vera Therapeutics
VERA
$1.38B
| – | – | -1,437,339 | Closed | -$60.8M |
|
|
TECX
32
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| – | – | -485,105 | Closed | -$22.4M |
|
|
ORKA
33
Oruka Therapeutics, Inc. Common Stock
ORKA
$554M
| – | – | -819,660 | Closed | -$15.9M |
|